Literature DB >> 9326708

The role of nitric oxide in vascular permeability after a thermal injury.

T Sozumi1.   

Abstract

The kinetics and role of nitric oxide (NO) on vascular permeability were studied using an ear thermal injury model. Vascular permeability was suppressed for 3 hours after a thermal injury by the preventive administration of nitric oxide synthase (NOS) inhibitors. The NO content in the injured region was significantly increased compared with the intact region. The plasma NO content was significantly increased in a biphasic pattern at 1 and 6 hours postinjury. NOS inhibitors administered as therapeutic treatment suppressed vascular permeability 1 and 6 hours postburn. Thus, NOS inhibitors may be effective in burn treatment.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9326708     DOI: 10.1097/00000637-199709000-00009

Source DB:  PubMed          Journal:  Ann Plast Surg        ISSN: 0148-7043            Impact factor:   1.539


  4 in total

Review 1.  Gammadelta T-cells: potential regulators of the post-burn inflammatory response.

Authors:  Martin G Schwacha
Journal:  Burns       Date:  2008-10-31       Impact factor: 2.744

2.  Functional significance of inducible nitric oxide synthase induction and protein nitration in the thermally injured cutaneous microvasculature.

Authors:  Andrew Rawlingson; Khalid Shendi; Stanley A Greenacre; Timothy G England; Andrew M Jenner; Robin N Poston; Barry Halliwell; Susan D Brain
Journal:  Am J Pathol       Date:  2003-04       Impact factor: 4.307

Review 3.  Guanylate cyclase inhibition by methylene blue as an option in the treatment of vasoplegia after a severe burn. A medical hypothesis.

Authors:  Jayme A Farina Junior; Andrea Carla Celotto; Marcelo Felix da Silva; Paulo Roberto B Evora
Journal:  Med Sci Monit       Date:  2012-05

Review 4.  Bench-to-bedside review: Burn-induced cerebral inflammation--a neglected entity?

Authors:  Michael A Flierl; Philip F Stahel; Basel M Touban; Kathryn M Beauchamp; Steven J Morgan; Wade R Smith; Kyros R Ipaktchi
Journal:  Crit Care       Date:  2009-06-29       Impact factor: 9.097

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.